Progress in Reye syndrome: epidemiology, biochemical mechanisms and animal models.
Kilpatrick-Smith
L
L
Department of Pediatrics, University of Pennsylvania Medical School, Philadelphia.
Hale
D E
DE
Douglas
S D
SD
D000293:Adolescent; D000818:Animals; D001241:Aspirin / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004195:Disease Models, Animal; D004731:Endotoxins / Q000009:adverse effects; D004926:Escherichia coli; D044943:Fatty Acid Desaturases / Q000172:deficiency; D005227:Fatty Acids / Q000378:metabolism; D005289:Ferrets; D006801:Humans; D008099:Liver / Q000378:metabolism; D051379:Mice; D008930:Mitochondria, Liver / Q000378:metabolism; D010084:Oxidation-Reduction; D007652:Oxo-Acid-Lyases / Q000172:deficiency; D051381:Rats; D012202:Reye Syndrome / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism*; D014481:United States; D014777:Virus Diseases / Q000150:complications
D004731:Endotoxins; D005227:Fatty Acids; D044943:Fatty Acid Desaturases; D007652:Oxo-Acid-Lyases; C021410:3-hydroxy-3-methylglutaryl-coenzyme A lyase; D001241:Aspirin